cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.453
+0.003 (0.71%)
At close: Nov 20, 2024, 4:00 PM
0.431
-0.022 (-4.90%)
After-hours: Nov 20, 2024, 7:57 PM EST
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 |
Revenue | 20.64 | 24.16 | 35.4 | 44.48 | 41.88 | 23.65 | Upgrade
|
Revenue Growth (YoY) | -21.55% | -31.77% | -20.41% | 6.20% | 77.09% | 5051.82% | Upgrade
|
Cost of Revenue | 7.55 | 9.18 | 13.07 | 14.5 | 15.51 | 9.14 | Upgrade
|
Gross Profit | 13.09 | 14.98 | 22.34 | 29.99 | 26.37 | 14.51 | Upgrade
|
Selling, General & Admin | 13.01 | 17.36 | 33.29 | 43.37 | 38.83 | 28.88 | Upgrade
|
Research & Development | 0.03 | 0.17 | 0.63 | 1.42 | 0.42 | - | Upgrade
|
Other Operating Expenses | 4.4 | 4.91 | 3.89 | 3.79 | 3.97 | - | Upgrade
|
Operating Expenses | 18.97 | 24.25 | 39.65 | 49.6 | 43.95 | 28.88 | Upgrade
|
Operating Income | -5.88 | -9.27 | -17.31 | -19.62 | -17.58 | -14.36 | Upgrade
|
Interest Expense | -0.03 | - | - | -0.03 | - | - | Upgrade
|
Interest & Investment Income | 0.06 | 0.06 | 0.02 | - | 0.04 | 0.08 | Upgrade
|
Other Non Operating Income (Expenses) | -0.06 | - | 0.24 | 0.03 | - | -0 | Upgrade
|
EBT Excluding Unusual Items | -5.9 | -9.2 | -17.06 | -19.62 | -17.54 | -14.29 | Upgrade
|
Merger & Restructuring Charges | - | - | -0.6 | - | - | - | Upgrade
|
Impairment of Goodwill | - | - | -56.67 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -0.7 | -0.7 | -0.03 | 0.55 | -0.93 | -0.61 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 0.09 | - | - | - | Upgrade
|
Asset Writedown | -13.22 | -13.22 | -4.29 | - | - | -0.44 | Upgrade
|
Other Unusual Items | 0.4 | 0.19 | 8.47 | -5.22 | 29.78 | -32.46 | Upgrade
|
Pretax Income | -19.42 | -22.94 | -70.08 | -24.29 | 11.31 | -47.79 | Upgrade
|
Income Tax Expense | - | - | - | -0.9 | -1.35 | -2.36 | Upgrade
|
Earnings From Continuing Operations | -19.42 | -22.94 | -70.08 | -23.39 | 12.65 | -45.43 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | -0.05 | -5 | Upgrade
|
Net Income | -19.42 | -22.94 | -70.08 | -23.39 | 12.6 | -50.43 | Upgrade
|
Preferred Dividends & Other Adjustments | 4 | 4 | 4 | 2.55 | 0.37 | - | Upgrade
|
Net Income to Common | -23.42 | -26.94 | -74.09 | -25.95 | 12.24 | -50.43 | Upgrade
|
Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
Shares Change (YoY) | 38.45% | 52.31% | 8.76% | 21.62% | 152.54% | 130.80% | Upgrade
|
EPS (Basic) | -8.01 | -13.32 | -55.80 | -21.26 | 12.47 | -126.87 | Upgrade
|
EPS (Diluted) | -8.02 | -13.32 | -55.80 | -21.26 | 12.47 | -126.87 | Upgrade
|
Free Cash Flow | -1.08 | -4.6 | -15.66 | -14.44 | -11.98 | -16.58 | Upgrade
|
Free Cash Flow Per Share | -0.37 | -2.27 | -11.79 | -11.82 | -11.94 | -41.70 | Upgrade
|
Gross Margin | 63.43% | 62.01% | 63.09% | 67.41% | 62.96% | 61.37% | Upgrade
|
Operating Margin | -28.50% | -38.37% | -48.90% | -44.10% | -41.98% | -60.72% | Upgrade
|
Profit Margin | -113.51% | -111.53% | -209.26% | -58.34% | 29.21% | -213.21% | Upgrade
|
Free Cash Flow Margin | -5.25% | -19.04% | -44.22% | -32.45% | -28.61% | -70.08% | Upgrade
|
EBITDA | -4.35 | -7.47 | -15.48 | -18.6 | -16.86 | -14.09 | Upgrade
|
EBITDA Margin | -21.09% | -30.92% | -43.72% | -41.81% | -40.26% | -59.59% | Upgrade
|
D&A For EBITDA | 1.53 | 1.8 | 1.83 | 1.02 | 0.72 | 0.27 | Upgrade
|
EBIT | -5.88 | -9.27 | -17.31 | -19.62 | -17.58 | -14.36 | Upgrade
|
EBIT Margin | -28.50% | -38.37% | -48.90% | -44.10% | -41.98% | -60.72% | Upgrade
|
Revenue as Reported | 20.64 | 24.16 | 35.4 | 44.48 | 41.88 | 23.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.